Botox Approved to Treat Urinary Incontinence

For use among people with certain neurologic conditions

WEDNESDAY, Aug. 24 (HealthDay News) -- Botox (onabotulinumtoxinA) has been approved by the U.S. Food and Drug Administration to treat urinary incontinence in people with neurological conditions such as spinal cord injury and multiple sclerosis.

Some people with these conditions have uncontrolled bladder contractions, which leads to inability to retain urine. Common treatments include medication or a catheter. The use of Botox involves injecting the drug into the bladder, relaxing the bladder. The drug's effects last for about nine months, the FDA said.

Botox was evaluated for this use in clinical studies involving 691 people. The most common adverse reactions included urinary tract infection and urinary retention. Botox also is FDA-approved for reducing facial frown lines, and treating chronic migraine, certain forms of muscle stiffness, severe underarm sweating and abnormal twitches of the eyelid.

The drug is marketed by Irvine, Calif.-based Allergan Inc.

More information

To learn more about incontinence, visit the U.S. National Library of Medicine.

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

Meeting the Needs of Family Members of ICU Patients
Critical Care Nursing Quarterly, October/December 2014
Free access will expire on December 22, 2014.


Dealing with the specter of phantom limb pain
Nursing2014 , November 2014
Free access will expire on December 8, 2014.


The Power of Nursing Peer Review
JONA: Journal of Nursing Administration, November 2014
Free access will expire on December 8, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events